Schedule
Pre-symposium Workshop (3 Dec)
| 1000 - 1600 | Laparo-Endoscopic Single-Site(LESS) Urological Surgery Workshop highlight: - Practicing LESS urological surgery in dry-lab and porcine models - Port insertion - Nephrectomy - Intra-corporeal suturing |
Symposium (4 - 5 Dec)
| 0900 - 0920 | Welcome Speech (CF NG) |
| 0920 - 1020 | Section 1: Kidney Cancer - The Facts |
| Epidemiology and Risk Factors of RCC (M GORE) | |
| Pathology of Kidney Cancer - from Gross to Molecular (KF TO) | |
| Molecular Markers for RCC (M GORE) | |
| 1020 - 1045 | Tea Break |
| 1045 - 1230 | Section 2: Small Renal Tumour Symposium |
| Role of Radiology in Diagnosis and Monitoring (SW SIM) | |
| SRM: How to Treat it? | |
| 1. Active Surveillance (SM HOU) | |
| 2. Partial Nephrectomy (S BHAYANI) | |
| 3. Tissue Ablation (P LEE) | |
| 4. Cryotherapy (F ZHOU) | |
| Case Discussion (TW CHONG) | |
| 1230 - 1400 | Lunch |
| 1400 - 1520 | Section 3: Tips and Tricks in Surgery |
| Laparoscopic Partial Nephrectomy - How I do it? (F LEE) | |
| Laparoscopic and Robotic Partial Nephrectomy - How I do it? (S BHAYANI) | |
| Does Margin Matter? (S YIP) | |
| Surgical Management of Locally Advanced RCC (C WOOD) | |
| 1520 - 1540 | Tea break |
| 1540 - 1700 | Section 4: Advance Kidney Cancer - What should be done? |
| Role of Cytoreductive Nephrectomy in the Era of Targeted Therapy (C WOOD) | |
| Systemic Therapy - from nothing to many things (M GORE) | |
| Adjuvant Therapy for Locally Advanced Disease, Status in 2009 (C WOOD) | |
| Targeted Therapy – Experience in Asia (WK KWONG) | |
| 1730 - 1830 | Lions Kidney Educational Centre Visiting Professorial Lecture in Nephrology/Urology Title: Renal Preserving Strategy in Kidney Cancers: Achievements and Challenges (C WOOD) |
| 0830 - 0930 | Paediatric Urology Symposium (J PIPPI SALLE) | |
| Update on the Management of PUJ Obstruction | ||
| Paediatric Kidney Tumours | ||
| 0930 - 1200 | Section 5: Live Demonstration - Partial Nephrectomy (S BHAYANI) | |
| 1200 - 1230 | Case Discussion (CW MAN) | |
| 1230 - 1400 | Lunch Symposium - The Role of mTOR Inhibitor in Renal Cancer (MH TAY) | |
| 1400 - 1515 | Section 6: What's New in Uro-oncology | |
| Before The Story Begin - Role of Chemoprevention and Screening in Prostate Cancer (MT NG) | ||
| Intermittent Hormonal Therapy for Prostate Cancer (L ZHOU) | ||
| What's New in Hormonal Therapy in Prostate Cancer? (CF NG) | ||
| Targeted Therapy - The role beyond Kidney Cancer (SY CHAN) | ||
| What is the Role of Zoledronic Acid in Uro-oncology? (MH TAY) | ||
| 1515 | Closing Remark (SY CHAN) | back to top |